Government of British Columbia Report issue

Government Phase 3 Phase 4

Organization Overview

First Clinical Trial
2007
NCT00501137
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ministry of Health, British Columbia | University of British Columbia - Centre for Heart Lung Innovation

Active Ingredients

Drugs in Phase 4 Trials (1)

ly3819253 (1 trial)

Drugs in Phase 3 Trials (1)

human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)

Drugs in Other Trials (1)

albuterol (proventil) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Condylomata Acuminata (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3